Professor Carolyn Sue

Professor
Medicine, Northern Clinical School
Kolling Institute of Medical Research

Telephone +61 2 9463 1828
Fax +61 2 9463 1058

Map

Selected grants

2014

  • Investigating of new ways to prevent neurodegeneration; Sue C; DVC Research/Bridging Support Grant.

2013

  • Sydney Neuroscience Network; Balleine B, Absalom N, Braddon-Mitchell D, Callaghan S, Chawla S, Christie M, Collins M, Einfeld S, Grieve S, Haber P, Hanrahan J, Harris A, Hickie I, Kassiou M, Kril J, Meikle S, Morris R, Ramos F, Rong Y, Sue C; DVC Research/Research Network Scheme (SyReNS).

2011

  • Practitioner Fellowship Level 1; Sue C; National Health and Medical Research Council (NHMRC)/Career Awards: Practitioner Fellowships.

2009

  • Neurologic effects of mutational load in MELAS syndrome; Sue C, Mackay-Sim A, Thorburn D; National Health and Medical Research Council (NHMRC)/Project Grants.

2008

  • Real-time cellular imaging system; Connor M, Keast J, Vaughan C, Christie M, Osborne P, Bagley E, Sue C; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2007

  • Understanding the role of mitochondria in the pathogenesis of parkinsons disease; Sue C; Parkinson's New South Wales Incorporated/Research Grants.

2006

  • Adult Stem Cell Research Facility; Sue C; Department of Health and Ageing (Federal)/National Adult Stem Cell Research Centre.

2004

  • The role of mitochondrial DNA in age-related hearing loss; Sue C, Wang J, Rochtchina E; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • Identification and characterisation of mitochondrial DNA defects in patients with mitochondrial myopathies; Sue C; DVC Research/Research and Development Scheme: Newly Appointed Staff (NAS).

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Kong, S., Chan, B., Park, J., Hill, K., Aitken, J., Cottle, L., Farghaian, H., Cole, A., Lay, P., Sue, C., et al (2014). Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes alpha-Synuclein externalization via exosomes. Human Molecular Genetics, 23(11), 2816-2833. [More Information]
  • Liang, C., Ahmad, K., Sue, C. (2014). The broadening spectrum of mitochondrial disease: Shifts in the diagnostic paradigm. Biochimica et Biophysica Acta (Molecular and Cell Biology of Lipids), 1840 (4), 1360-1367. [More Information]
  • Abrahamsen, G., Fan, Y., Matigian, N., Wali, G., Bellette, B., Sutharsan, R., Raju, J., Wood, S., Veivers, D., Sue, C., et al (2013). A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations. Disease Models & Mechanisms, 6(2), 489-502. [More Information]
  • Ng, K., Kumar, K., Sue, C., Burke, D. (2013). Axonal excitability during ischemia in MELAS. Muscle and Nerve, 47(5), 762-765. [More Information]
  • Dobson-Stone, C., Hallupp, M., Loy, C., Thompson, E., Haan, E., Sue, C., Panegyres, P., Razquin, C., Seijo-Martinez, M., Rene, R., et al (2013). C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PLoS One, 8(2), 1-6. [More Information]
  • Tomlinson, S., Rajakulendran, S., Tan, S., Graves, T., Bamiou, D., Labrum, R., Burke, D., Sue, C., Giunti, P., Schorge, S., et al (2013). Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. Journal of Neurology, Neurosurgery, and Psychiatry, 84(10), 1107-1112. [More Information]
  • Davis, R., Liang, C., Edema-Hildebrand, F., Riley, C., Needham, M., Sue, C. (2013). Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology, 81(21), 1819-1826. [More Information]
  • Kumar, K., Ramirez, A., Gobel, A., Kresojevic, N., Svetel, M., Lohmann, K., Sue, C., Rolfs, A., Mazzulli, J., Alcalay, R., et al (2013). Glucocerebrosidase mutations in a Serbian Parkinson's disease population. European Journal of Neurology, 20(2), 402-405. [More Information]
  • Woodbridge, P., Liang, C., Davis, R., Vandebona, H., Sue, C. (2013). POLG mutations in Australian patients with mitochondrial disease. Internal Medicine Journal, 43(2), 150-156. [More Information]
  • Kumar, K., Blair, N., Vandebona, H., Liang, C., Ng, K., Sharpe, D., Grünewald, A., Gölnitz, U., Saviouk, V., Rolfs, A., Sue, C., et al (2013). Targeted next generation sequencing in SPAST-negative hereditary spastic paraplegia. Journal of Neurology, 260(10), 2516-2522. [More Information]
  • Lohmann, K., Wilcox, R., Winkler, S., Ramirez, A., Rakovic, A., Park, J., Arns, B., Lohnau, T., Groen, J., Kasten, M., Kumar, K., Sue, C., et al (2013). Whispering Dysphonia (DYT4 dystonia) Is Caused by a Mutation in the TUBB4 Gene. Annals of Neurology, 73(4), 537-545. [More Information]
  • Chang, F., Mehta, P., Koentjoro, B., Latt, M., Blair, N., Nicholson, G., Sue, C., Fung, V. (2012). "Dancing feet dyskinesias": a clue to parkin gene mutations. Movement Disorders, 27(4), 587-588. [More Information]
  • Wilkins, E., Rubio, J., Kotschet, K., Cowie, T., Boon, W., O'Hely, M., Burfoot, R., Wang, W., Sue, C., Speed, T., et al (2012). A DNA resequencing array for genes involved in Parkinson's disease. Parkinsonism & Related Disorders, 18(4), 386-390. [More Information]
  • Grunewald, A., Arns, B., Seibler, P., Rakovic, A., Munchau, A., Ramirez, A., Sue, C., Klein, C. (2012). ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome. Neurobiology of Aging, 33(8), 1843.e1-1843.e7. [More Information]
  • Kumar, K., Weissbach, A., Heldmann, M., Kasten, M., Tunc, S., Sue, C., Svetel, M., Kostic, V., Segura-Aguilar, J., Ramirez, A., et al (2012). Frequency of the D620N mutation in VPS35 in Parkinson disease. JAMA Neurology (formerly Archives of Neurology), 69(10), 1360-1364. [More Information]
  • Rojana-udomsart, A., James, I., Castley, A., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Witt, C., et al (2012). High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes. Journal of Neuroimmunology, 250(1-2), 77-82. [More Information]
  • Kumar, K., Sue, C., Burke, D., Ng, K. (2012). Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation - A neurophysiological study using excitability techniques. Clinical Neurophysiology, 123(7), 1454-1459. [More Information]
  • Koentjoro, B., Park, J., Ha, A., Sue, C. (2012). Phenotypic variability of parkin mutations in single kindred. Movement Disorders, 27(10), 1299-1303. [More Information]
  • Vandebona, H., Kerr, N., Liang, C., Sue, C. (2012). SPAST mutations in Australian patients with hereditary spastic paraplegia. Internal Medicine Journal, 42(12), 1342-1346. [More Information]
  • Gopinath, B., Sue, C., Kifley, A., Mitchell, P. (2012). The Association Between Olfactory Impairment and Total Mortality in Older Adults. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 67A(2), 204-209. [More Information]
  • Ha, A., Parratt, K., Rendtorff, N., Lodahl, M., Ng, K., Rowe, D., Sue, C., Hayes, M., Tranebjaerg, L., Fung, V. (2012). The Phenotypic Spectrum of Dystonia in Mohr-Tranebjaerg Syndrome. Movement Disorders, 27(8), 1034-1040. [More Information]
  • Schmidt, A., Kumar, K., Redyk, K., Grunewald, A., Leben, M., Munchau, A., Sue, C., Hagenah, J., Hartmann, H., Lohmann, K., et al (2012). Two Faces of the Same Coin: Benign Familial Infantile Seizures and Paroxysmal Kinesigenic Dyskinesia Caused by PRRT2 Mutations. JAMA Neurology (formerly Archives of Neurology), 69(5), 668-670. [More Information]
  • Halter, J., Schüpbach, W., Casali, C., Elhasid, R., Fay, K., Hammans, S., Illa, I., Kappeler, L., Krähenbühl, S., et al, Sue, C. (2011). Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A consensus conference proposal for a standardized approach. Bone Marrow Transplantation, 46(3), 330-337. [More Information]
  • Kumar, K., Liang, C., Needham, M., Burke, D., Sue, C., Ng, K. (2011). Axonal hyperpolarization in inclusion-body myopathy, paget disease of the bone, and frontotemporal dementia (IBMPFD). Muscle and Nerve, 44(2), 191-196. [More Information]
  • Miteff, F., Faulder, K., Goh, A., Steinfort, B., Sue, C., Harrington, T. (2011). Mechanical Thrombectomy with a Self-Expanding Retrievable Intracranial Stent (Solitaire AB): Experience in 26 Patients with Acute Cerebral Artery Occlusion. American Journal Of Neuroradiology, 32(6), 1078-1081. [More Information]
  • Gopinath, B., Anstey, K., Sue, C., Kifley, A., Mitchell, P. (2011). Olfactory Impairment in Older Adults Is Associated With Depressive Symptoms and Poorer Quality of Life Scores. American Journal of Geriatric Psychiatry, 19(9), 830-834. [More Information]
  • Park, J., Mehta, P., Cooper, A., Veivers, D., Heimbach, A., Stiller, B., Kubisch, C., Fung, V., Krainc, D., Mackay-Sim, A., Sue, C. (2011). Pathogenic Effects of Novel Mutations in the P-Type ATPase ATP13A2 (PARK9) Causing Kufor-Rakeb Syndrome, a Form of Early-Onset Parkinsonism. Human Mutation, 32(8), 956-964. [More Information]
  • Davis, R., Sue, C. (2011). The genetics of mitochondrial disease. Seminars in Neurology, 31(5), 519-530. [More Information]
  • Mar, J., Matigian, N., Mackay-Sim, A., Mellick, G., Sue, C., Silburn, P., McGrath, J., Quackenbush, J., Wells, C. (2011). Variance of Gene Expression Identifies Altered Network Constraints in Neurological Disease. PLoS Genetics, 7(8), 1-12. [More Information]
  • Kumar, K., Ng, K., Vandebona, H., Davis, M., Sue, C. (2010). A novel CLCN1 mutation (G1652A) causing a mild phenotype of Thomsen disease. Muscle and Nerve, 41(3), 412-415. [More Information]
  • Ha, A., Sue, C. (2010). ADEM presenting as a movement disorder. Movement Disorders, 25(14), 2464-6. [More Information]
  • Matigian, N., Abrahamsen, G., Sutharsan, R., Cook, A., Vitale, A., Nouwens, A., Bellette, B., An, J., Anderson, M., Beckhouse, A., Sue, C., et al (2010). Disease-specific, neurosphere-derived cells as models for brain disorders. Disease Models and Mechanisms, 3(11-12), 785-798. [More Information]
  • Sue, C. (2010). Mitochondrial disease: recognising more than just the tip of the iceberg. Medical Journal of Australia, 193(4), 195-196. [More Information]
  • Grunewald, A., Voges, L., Rakovic, A., Kasten, M., Vandebona, H., Hemmelmann, C., Lohmann - Hedrich, K., Orolicki, S., Ramirez, A., Schapira, A., Sue, C., et al (2010). Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts. PLoS One, 5(9), e12962-1-e12962-6. [More Information]
  • Ng, K., Winter, S., Sue, C., Burke, D. (2010). Preserved motor axonal membrane potential in mitochondrial disease. Journal of Neurology, Neurosurgery and Psychiatry, 81(8), 844-846. [More Information]
  • Karpa, M., Gopinath, B., Rochtchina, E., Wang, J., Cumming, R., Sue, C., Mitchell, P. (2010). Prevalence and neurodegenerative or other associations with olfactory impairment in an older community. Journal of Aging and Health, 22(2), 154-168. [More Information]
  • Kumar, K., Needham, M., Mina, K., Davis, M., Brewer, J., Staples, C., Ng, K., Sue, C., Mastaglia, F. (2010). Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings. Neuromuscular Disorders, 20(5), 330-334. [More Information]
  • Duley, J., Hammond, S., Herkes, G., Hirano, M., Sue, C. (2009). Mitochondrial disease mimicking Charcot-Marie Tooth disease. BMJ Case Reports, 2009, pii: bcr06. [More Information]
  • Mehta, P., Mellick, G., Rowe, D., Halliday, G., Jones, M., Manwaring, N., Vandebona, H., Silburn, P., Wang, J., Mitchell, P., Sue, C. (2009). Mitochondrial DNA Haplogroups J and K are not Protective for Parkinson's Disease in the Australian Community. Movement Disorders, 24(2), 290-292. [More Information]
  • SanGiovanni, J., Arking, D., Iyengar, S., Elashoff, M., Clemons, T., Reed, G., Henning, A., Sivakumaran, T., Xu, X., DeWan, A., Rochtchina, E., Sue, C., Wang, J., Mitchell, P., et al (2009). Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One, 4(5), 1-8. [More Information]
  • Vandebona, H., Mitchell, P., Manwaring, N., Griffiths, K., Gopinath, B., Wang, J., Sue, C. (2009). Prevalence of mitochondrial DNA 1555 A>G mutation in Adults of European Descent. New England Journal of Medicine, 360(6), 642-644. [More Information]
  • Luangtrakool, K., Tate, F., Shepherd, R., Campbell, S., Sue, C., Lertrit, P. (2008). Characterization of 2-Deoxy-D-Glucose Uptake in Fibroblast Cultures Derived from Patients with A3243G Mitochondrial DNA Mutation. Southeast Asian Journal of Tropical Medicine and Public Health, 39(4), 745-752. [More Information]
  • Manwaring, N., Wang, J., Mitchell, P., Sue, C. (2008). Mitochondrial DNA disease prevalence: still under recognised? Annals of Neurology, 64(4), 471-471. [More Information]
  • Grünewald, A., Djarmati, A., Lohmann - Hedrich, K., Farrell, K., Zeller, J., Papengut, F., Allert, N., Petersen, B., Fung, V., Sue, C., et al (2008). Myoclonus-dystonia: significance of large SGCE deletions. Human Mutation, 29(2), 1-15. [More Information]
  • Sutherland, G., Mellick, G., Sue, C., Chan, D., Rowe, D., Silburn, P., Halliday, G. (2007). A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease. Neuroscience Letters, 414(2), 170-173. [More Information]
  • Duley, J., Hammond, S., Herkes, G., Hirano, M., Sue, C. (2007). Mitochondrial disease mimicking Charcot-Marie Tooth disease. Journal of Neurology, Neurosurgery and Psychiatry, 78(1), 99-100. [More Information]
  • Manwaring, N., Jones, M., Wang, J., Rochtchina, E., Howard, C., Newall, P., Mitchell, P., Sue, C. (2007). Mitochondrial DNA haplogroups and age-related hearing loss. Archives Of Otolaryngology-Head and Neck Surgery, 133, 929-933. [More Information]
  • Jones, M., Manwaring, N., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2007). Mitochondrial DNA haplogroups and age-related maculopathy. Archives of Ophthalmology, 125(9), 1235-1240. [More Information]
  • Mehta, P., Kifley, A., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2007). Population prevalence and incidence of Parkinson's disease in an Australian community. Internal Medicine Journal, 37(12), 812-814. [More Information]
  • Manwaring, N., Jones, M., Wang, J., Rochtchina, E., Howard, C., Mitchell, P., Sue, C. (2007). Population prevalence of the MELAS A3243G mutation. Mitochondrion, 7(3), 230-233. [More Information]
  • Huang, Y., Halliday, G., Vandebona, H., Mellick, G., Mastaglia, F., Stevens, J., Kwok, J., Garlepp, M., Silburn, P., Horne, M., Rowe, D., Sue, C., et al (2007). Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease. Movement Disorders, 22(7), 982-989. [More Information]
  • Trenell, M., Sue, C., Thompson, C., Kemp, G. (2007). Supplemental oxygen and muscle metabolism in mitochondrial myopathy patients. European Journal of Applied Physiology, 99(5), 541-547. [More Information]
  • Trenell, M., Sue, C., Kemp, G., Sachinwalla, T., Thompson, C. (2006). Aerobic exercise and muscle metabolism in patients with mitochondrial myopathy. Muscle and Nerve, 33(4), 524-531. [More Information]
  • Trenell, M., Rooney, K., Sue, C., Thompson, C. (2006). Compression garments and recovery from eccentric exercise: A 31P-MRS study. Journal of Sports Science and Medicine, 5(1), 106-114.
  • Trenell, M., Thompson, C., Sue, C. (2006). Exercise and Myotonic Dystrophy: A (31)P Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging Case Study. Annals of Neurology, 59(5), 871-872. [More Information]
  • Shepherd, R., Checcarelli, N., Naini, A., De Vivo, D., DiMauro, S., Sue, C. (2006). Measurement of ATP production in mitochondrial disorders. Journal of Inherited Metabolic Disease (JIMD), 29(1), 86-91. [More Information]
  • Manwaring, N., Jones, M., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2006). Prevalence of mitochondrial DNA haplogroups in an Australian population. Internal Medicine Journal, 36(8), 530-533. [More Information]
  • Willaims, J., Sue, C., Banting, G., Yang, H., Glerum, D., Hendrickson, W., Schon, E. (2005). Crystal Structure of Human SCO1: Implications for Redox Signaling by a Mitochondrial Cytochrome c Oxidase "Assembly" Protein. Journal of Biological Chemistry, 280(15), 15202-15211. [More Information]
  • Jones, M., Mitchell, P., Wang, J., Sue, C. (2004). MELAS A3243G Mitochondrial DNA Mutation And Age Related Maculopathy. American Journal of Ophthalmology, 138(6), 1051-1053. [More Information]
  • Pons, R., Andreu, A., Checcarelli, N., Vila, M., Engelstad, K., Sue, C., Shungu, D., Haggerty, R., De Vivo, D., DiMauro, S. (2004). Mitochondrial DNA abnormalities and autistic spectrum disorders. The Journal of Pediatrics, 144(1), 81-85.
  • Akman, C., Sue, C., Shanske, S., Tanji, K., Bonilla, E., Ojaimi, J., Krishna, S., Schubert, R., DiMauro, S. (2004). Mitochondrial DNA Deletion in a Child With Megaloblastic Anemia and Recurrent Encephalopathy. Journal of Child Neurology, 19(4), 258-261.
  • Sacconi, S., Salviati, L., Sue, C., Shanske, S., Davidson, M., Bonilla, E., Naini, A., De Vivo, D., DiMauro, S. (2003). Mutation Screening in Patients With Isolated Cytochrome c Oxidase Deficiency. Pediatric Research: international journal of human developmental biology, 53(2), 224-230.

Conferences

  • Tsang, V., Parker, N., Cassano, J., Dwight, T., Sue, C., Veivers, D., Robinson, B., Benn, D., Clifton-Bligh, R. (2012). Interaction between hypoxia and mutations in the SDH subunit genes associated with phaeochromocytoma/paragangliomas. 2012 Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology, Gold Coast, Queensland, Australia.

2014

  • Kong, S., Chan, B., Park, J., Hill, K., Aitken, J., Cottle, L., Farghaian, H., Cole, A., Lay, P., Sue, C., et al (2014). Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes alpha-Synuclein externalization via exosomes. Human Molecular Genetics, 23(11), 2816-2833. [More Information]
  • Liang, C., Ahmad, K., Sue, C. (2014). The broadening spectrum of mitochondrial disease: Shifts in the diagnostic paradigm. Biochimica et Biophysica Acta (Molecular and Cell Biology of Lipids), 1840 (4), 1360-1367. [More Information]

2013

  • Abrahamsen, G., Fan, Y., Matigian, N., Wali, G., Bellette, B., Sutharsan, R., Raju, J., Wood, S., Veivers, D., Sue, C., et al (2013). A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations. Disease Models & Mechanisms, 6(2), 489-502. [More Information]
  • Ng, K., Kumar, K., Sue, C., Burke, D. (2013). Axonal excitability during ischemia in MELAS. Muscle and Nerve, 47(5), 762-765. [More Information]
  • Dobson-Stone, C., Hallupp, M., Loy, C., Thompson, E., Haan, E., Sue, C., Panegyres, P., Razquin, C., Seijo-Martinez, M., Rene, R., et al (2013). C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PLoS One, 8(2), 1-6. [More Information]
  • Tomlinson, S., Rajakulendran, S., Tan, S., Graves, T., Bamiou, D., Labrum, R., Burke, D., Sue, C., Giunti, P., Schorge, S., et al (2013). Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. Journal of Neurology, Neurosurgery, and Psychiatry, 84(10), 1107-1112. [More Information]
  • Davis, R., Liang, C., Edema-Hildebrand, F., Riley, C., Needham, M., Sue, C. (2013). Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology, 81(21), 1819-1826. [More Information]
  • Kumar, K., Ramirez, A., Gobel, A., Kresojevic, N., Svetel, M., Lohmann, K., Sue, C., Rolfs, A., Mazzulli, J., Alcalay, R., et al (2013). Glucocerebrosidase mutations in a Serbian Parkinson's disease population. European Journal of Neurology, 20(2), 402-405. [More Information]
  • Woodbridge, P., Liang, C., Davis, R., Vandebona, H., Sue, C. (2013). POLG mutations in Australian patients with mitochondrial disease. Internal Medicine Journal, 43(2), 150-156. [More Information]
  • Kumar, K., Blair, N., Vandebona, H., Liang, C., Ng, K., Sharpe, D., Grünewald, A., Gölnitz, U., Saviouk, V., Rolfs, A., Sue, C., et al (2013). Targeted next generation sequencing in SPAST-negative hereditary spastic paraplegia. Journal of Neurology, 260(10), 2516-2522. [More Information]
  • Lohmann, K., Wilcox, R., Winkler, S., Ramirez, A., Rakovic, A., Park, J., Arns, B., Lohnau, T., Groen, J., Kasten, M., Kumar, K., Sue, C., et al (2013). Whispering Dysphonia (DYT4 dystonia) Is Caused by a Mutation in the TUBB4 Gene. Annals of Neurology, 73(4), 537-545. [More Information]

2012

  • Chang, F., Mehta, P., Koentjoro, B., Latt, M., Blair, N., Nicholson, G., Sue, C., Fung, V. (2012). "Dancing feet dyskinesias": a clue to parkin gene mutations. Movement Disorders, 27(4), 587-588. [More Information]
  • Wilkins, E., Rubio, J., Kotschet, K., Cowie, T., Boon, W., O'Hely, M., Burfoot, R., Wang, W., Sue, C., Speed, T., et al (2012). A DNA resequencing array for genes involved in Parkinson's disease. Parkinsonism & Related Disorders, 18(4), 386-390. [More Information]
  • Grunewald, A., Arns, B., Seibler, P., Rakovic, A., Munchau, A., Ramirez, A., Sue, C., Klein, C. (2012). ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome. Neurobiology of Aging, 33(8), 1843.e1-1843.e7. [More Information]
  • Kumar, K., Weissbach, A., Heldmann, M., Kasten, M., Tunc, S., Sue, C., Svetel, M., Kostic, V., Segura-Aguilar, J., Ramirez, A., et al (2012). Frequency of the D620N mutation in VPS35 in Parkinson disease. JAMA Neurology (formerly Archives of Neurology), 69(10), 1360-1364. [More Information]
  • Rojana-udomsart, A., James, I., Castley, A., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Witt, C., et al (2012). High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes. Journal of Neuroimmunology, 250(1-2), 77-82. [More Information]
  • Tsang, V., Parker, N., Cassano, J., Dwight, T., Sue, C., Veivers, D., Robinson, B., Benn, D., Clifton-Bligh, R. (2012). Interaction between hypoxia and mutations in the SDH subunit genes associated with phaeochromocytoma/paragangliomas. 2012 Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology, Gold Coast, Queensland, Australia.
  • Kumar, K., Sue, C., Burke, D., Ng, K. (2012). Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation - A neurophysiological study using excitability techniques. Clinical Neurophysiology, 123(7), 1454-1459. [More Information]
  • Koentjoro, B., Park, J., Ha, A., Sue, C. (2012). Phenotypic variability of parkin mutations in single kindred. Movement Disorders, 27(10), 1299-1303. [More Information]
  • Vandebona, H., Kerr, N., Liang, C., Sue, C. (2012). SPAST mutations in Australian patients with hereditary spastic paraplegia. Internal Medicine Journal, 42(12), 1342-1346. [More Information]
  • Gopinath, B., Sue, C., Kifley, A., Mitchell, P. (2012). The Association Between Olfactory Impairment and Total Mortality in Older Adults. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 67A(2), 204-209. [More Information]
  • Ha, A., Parratt, K., Rendtorff, N., Lodahl, M., Ng, K., Rowe, D., Sue, C., Hayes, M., Tranebjaerg, L., Fung, V. (2012). The Phenotypic Spectrum of Dystonia in Mohr-Tranebjaerg Syndrome. Movement Disorders, 27(8), 1034-1040. [More Information]
  • Schmidt, A., Kumar, K., Redyk, K., Grunewald, A., Leben, M., Munchau, A., Sue, C., Hagenah, J., Hartmann, H., Lohmann, K., et al (2012). Two Faces of the Same Coin: Benign Familial Infantile Seizures and Paroxysmal Kinesigenic Dyskinesia Caused by PRRT2 Mutations. JAMA Neurology (formerly Archives of Neurology), 69(5), 668-670. [More Information]

2011

  • Halter, J., Schüpbach, W., Casali, C., Elhasid, R., Fay, K., Hammans, S., Illa, I., Kappeler, L., Krähenbühl, S., et al, Sue, C. (2011). Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A consensus conference proposal for a standardized approach. Bone Marrow Transplantation, 46(3), 330-337. [More Information]
  • Kumar, K., Liang, C., Needham, M., Burke, D., Sue, C., Ng, K. (2011). Axonal hyperpolarization in inclusion-body myopathy, paget disease of the bone, and frontotemporal dementia (IBMPFD). Muscle and Nerve, 44(2), 191-196. [More Information]
  • Miteff, F., Faulder, K., Goh, A., Steinfort, B., Sue, C., Harrington, T. (2011). Mechanical Thrombectomy with a Self-Expanding Retrievable Intracranial Stent (Solitaire AB): Experience in 26 Patients with Acute Cerebral Artery Occlusion. American Journal Of Neuroradiology, 32(6), 1078-1081. [More Information]
  • Gopinath, B., Anstey, K., Sue, C., Kifley, A., Mitchell, P. (2011). Olfactory Impairment in Older Adults Is Associated With Depressive Symptoms and Poorer Quality of Life Scores. American Journal of Geriatric Psychiatry, 19(9), 830-834. [More Information]
  • Park, J., Mehta, P., Cooper, A., Veivers, D., Heimbach, A., Stiller, B., Kubisch, C., Fung, V., Krainc, D., Mackay-Sim, A., Sue, C. (2011). Pathogenic Effects of Novel Mutations in the P-Type ATPase ATP13A2 (PARK9) Causing Kufor-Rakeb Syndrome, a Form of Early-Onset Parkinsonism. Human Mutation, 32(8), 956-964. [More Information]
  • Davis, R., Sue, C. (2011). The genetics of mitochondrial disease. Seminars in Neurology, 31(5), 519-530. [More Information]
  • Mar, J., Matigian, N., Mackay-Sim, A., Mellick, G., Sue, C., Silburn, P., McGrath, J., Quackenbush, J., Wells, C. (2011). Variance of Gene Expression Identifies Altered Network Constraints in Neurological Disease. PLoS Genetics, 7(8), 1-12. [More Information]

2010

  • Kumar, K., Ng, K., Vandebona, H., Davis, M., Sue, C. (2010). A novel CLCN1 mutation (G1652A) causing a mild phenotype of Thomsen disease. Muscle and Nerve, 41(3), 412-415. [More Information]
  • Ha, A., Sue, C. (2010). ADEM presenting as a movement disorder. Movement Disorders, 25(14), 2464-6. [More Information]
  • Matigian, N., Abrahamsen, G., Sutharsan, R., Cook, A., Vitale, A., Nouwens, A., Bellette, B., An, J., Anderson, M., Beckhouse, A., Sue, C., et al (2010). Disease-specific, neurosphere-derived cells as models for brain disorders. Disease Models and Mechanisms, 3(11-12), 785-798. [More Information]
  • Sue, C. (2010). Mitochondrial disease: recognising more than just the tip of the iceberg. Medical Journal of Australia, 193(4), 195-196. [More Information]
  • Grunewald, A., Voges, L., Rakovic, A., Kasten, M., Vandebona, H., Hemmelmann, C., Lohmann - Hedrich, K., Orolicki, S., Ramirez, A., Schapira, A., Sue, C., et al (2010). Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts. PLoS One, 5(9), e12962-1-e12962-6. [More Information]
  • Ng, K., Winter, S., Sue, C., Burke, D. (2010). Preserved motor axonal membrane potential in mitochondrial disease. Journal of Neurology, Neurosurgery and Psychiatry, 81(8), 844-846. [More Information]
  • Karpa, M., Gopinath, B., Rochtchina, E., Wang, J., Cumming, R., Sue, C., Mitchell, P. (2010). Prevalence and neurodegenerative or other associations with olfactory impairment in an older community. Journal of Aging and Health, 22(2), 154-168. [More Information]
  • Kumar, K., Needham, M., Mina, K., Davis, M., Brewer, J., Staples, C., Ng, K., Sue, C., Mastaglia, F. (2010). Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings. Neuromuscular Disorders, 20(5), 330-334. [More Information]

2009

  • Duley, J., Hammond, S., Herkes, G., Hirano, M., Sue, C. (2009). Mitochondrial disease mimicking Charcot-Marie Tooth disease. BMJ Case Reports, 2009, pii: bcr06. [More Information]
  • Mehta, P., Mellick, G., Rowe, D., Halliday, G., Jones, M., Manwaring, N., Vandebona, H., Silburn, P., Wang, J., Mitchell, P., Sue, C. (2009). Mitochondrial DNA Haplogroups J and K are not Protective for Parkinson's Disease in the Australian Community. Movement Disorders, 24(2), 290-292. [More Information]
  • SanGiovanni, J., Arking, D., Iyengar, S., Elashoff, M., Clemons, T., Reed, G., Henning, A., Sivakumaran, T., Xu, X., DeWan, A., Rochtchina, E., Sue, C., Wang, J., Mitchell, P., et al (2009). Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One, 4(5), 1-8. [More Information]
  • Vandebona, H., Mitchell, P., Manwaring, N., Griffiths, K., Gopinath, B., Wang, J., Sue, C. (2009). Prevalence of mitochondrial DNA 1555 A>G mutation in Adults of European Descent. New England Journal of Medicine, 360(6), 642-644. [More Information]

2008

  • Luangtrakool, K., Tate, F., Shepherd, R., Campbell, S., Sue, C., Lertrit, P. (2008). Characterization of 2-Deoxy-D-Glucose Uptake in Fibroblast Cultures Derived from Patients with A3243G Mitochondrial DNA Mutation. Southeast Asian Journal of Tropical Medicine and Public Health, 39(4), 745-752. [More Information]
  • Manwaring, N., Wang, J., Mitchell, P., Sue, C. (2008). Mitochondrial DNA disease prevalence: still under recognised? Annals of Neurology, 64(4), 471-471. [More Information]
  • Grünewald, A., Djarmati, A., Lohmann - Hedrich, K., Farrell, K., Zeller, J., Papengut, F., Allert, N., Petersen, B., Fung, V., Sue, C., et al (2008). Myoclonus-dystonia: significance of large SGCE deletions. Human Mutation, 29(2), 1-15. [More Information]

2007

  • Sutherland, G., Mellick, G., Sue, C., Chan, D., Rowe, D., Silburn, P., Halliday, G. (2007). A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease. Neuroscience Letters, 414(2), 170-173. [More Information]
  • Duley, J., Hammond, S., Herkes, G., Hirano, M., Sue, C. (2007). Mitochondrial disease mimicking Charcot-Marie Tooth disease. Journal of Neurology, Neurosurgery and Psychiatry, 78(1), 99-100. [More Information]
  • Manwaring, N., Jones, M., Wang, J., Rochtchina, E., Howard, C., Newall, P., Mitchell, P., Sue, C. (2007). Mitochondrial DNA haplogroups and age-related hearing loss. Archives Of Otolaryngology-Head and Neck Surgery, 133, 929-933. [More Information]
  • Jones, M., Manwaring, N., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2007). Mitochondrial DNA haplogroups and age-related maculopathy. Archives of Ophthalmology, 125(9), 1235-1240. [More Information]
  • Mehta, P., Kifley, A., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2007). Population prevalence and incidence of Parkinson's disease in an Australian community. Internal Medicine Journal, 37(12), 812-814. [More Information]
  • Manwaring, N., Jones, M., Wang, J., Rochtchina, E., Howard, C., Mitchell, P., Sue, C. (2007). Population prevalence of the MELAS A3243G mutation. Mitochondrion, 7(3), 230-233. [More Information]
  • Huang, Y., Halliday, G., Vandebona, H., Mellick, G., Mastaglia, F., Stevens, J., Kwok, J., Garlepp, M., Silburn, P., Horne, M., Rowe, D., Sue, C., et al (2007). Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease. Movement Disorders, 22(7), 982-989. [More Information]
  • Trenell, M., Sue, C., Thompson, C., Kemp, G. (2007). Supplemental oxygen and muscle metabolism in mitochondrial myopathy patients. European Journal of Applied Physiology, 99(5), 541-547. [More Information]

2006

  • Trenell, M., Sue, C., Kemp, G., Sachinwalla, T., Thompson, C. (2006). Aerobic exercise and muscle metabolism in patients with mitochondrial myopathy. Muscle and Nerve, 33(4), 524-531. [More Information]
  • Trenell, M., Rooney, K., Sue, C., Thompson, C. (2006). Compression garments and recovery from eccentric exercise: A 31P-MRS study. Journal of Sports Science and Medicine, 5(1), 106-114.
  • Trenell, M., Thompson, C., Sue, C. (2006). Exercise and Myotonic Dystrophy: A (31)P Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging Case Study. Annals of Neurology, 59(5), 871-872. [More Information]
  • Shepherd, R., Checcarelli, N., Naini, A., De Vivo, D., DiMauro, S., Sue, C. (2006). Measurement of ATP production in mitochondrial disorders. Journal of Inherited Metabolic Disease (JIMD), 29(1), 86-91. [More Information]
  • Manwaring, N., Jones, M., Wang, J., Rochtchina, E., Mitchell, P., Sue, C. (2006). Prevalence of mitochondrial DNA haplogroups in an Australian population. Internal Medicine Journal, 36(8), 530-533. [More Information]

2005

  • Willaims, J., Sue, C., Banting, G., Yang, H., Glerum, D., Hendrickson, W., Schon, E. (2005). Crystal Structure of Human SCO1: Implications for Redox Signaling by a Mitochondrial Cytochrome c Oxidase "Assembly" Protein. Journal of Biological Chemistry, 280(15), 15202-15211. [More Information]

2004

  • Jones, M., Mitchell, P., Wang, J., Sue, C. (2004). MELAS A3243G Mitochondrial DNA Mutation And Age Related Maculopathy. American Journal of Ophthalmology, 138(6), 1051-1053. [More Information]
  • Pons, R., Andreu, A., Checcarelli, N., Vila, M., Engelstad, K., Sue, C., Shungu, D., Haggerty, R., De Vivo, D., DiMauro, S. (2004). Mitochondrial DNA abnormalities and autistic spectrum disorders. The Journal of Pediatrics, 144(1), 81-85.
  • Akman, C., Sue, C., Shanske, S., Tanji, K., Bonilla, E., Ojaimi, J., Krishna, S., Schubert, R., DiMauro, S. (2004). Mitochondrial DNA Deletion in a Child With Megaloblastic Anemia and Recurrent Encephalopathy. Journal of Child Neurology, 19(4), 258-261.

2003

  • Sacconi, S., Salviati, L., Sue, C., Shanske, S., Davidson, M., Bonilla, E., Naini, A., De Vivo, D., DiMauro, S. (2003). Mutation Screening in Patients With Isolated Cytochrome c Oxidase Deficiency. Pediatric Research: international journal of human developmental biology, 53(2), 224-230.

To update your profile click here. For support on your academic profile contact .